A Study to Identify Genes Responsible for Venous Thromboembolism (VTE) in Families

Overview

About this study

The purpose of this study is to identify susceptibility genes for venous thromboembolism (VTE) using conventional and novel genetic-epidemiologic methods in high-risk VTE families.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Persons affected with venous thromboembolism (VTE): 
    • VTE index cases are defined as adult persons with objectively-diagnosed VTE.
    • Relatives with VTE are defined as first, second, or third degree relatives who have been reported to have VTE, and the diagnosis has been verified (whenever possible) with medical records.
  • Unaffected relatives of VTE cases:
    • These will be adult or child living relatives (first, second, or third degree blood relatives) or persons related by marriage to previously identified VTE cases.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mariza de Andrade, Ph.D.

Closed for enrollment

Contact information:

Louise Durst R.N.

(507)284-1838

durst.louise@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20317229

Mayo Clinic Footer